预测在急诊室就诊的COVID-19患者进入重症监护病房的风险:CROSS评分的制定和评估

IF 8.2 1区 医学 Q1 IMMUNOLOGY Clinical Infectious Diseases Pub Date : 2025-01-10 DOI:10.1093/cid/ciaf006
Weiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, Florian Kurth, Tilman Lingscheid, Charlotte Thibeault, Hans-Jakob Meyer, Norbert Suttorp, Mirja Mittermaier, Melanie Stecher, Margarete Scherer, Marina Hagen, Lazar Mitrov, Ramsia Geisler, Katharina S Appel, Sina M Hopff, Carolin Koll, Susana M Nunes de Miranda, Christina Weismantel, Jens-Peter Reese, Peter Heuschmann, Olga Miljukov, Carolin Nürnberger, Leif-Erik Sander, Jörg Janne Vehreschild, Martin Witzenrath, Maarten van Smeden, Thomas Zoller
{"title":"预测在急诊室就诊的COVID-19患者进入重症监护病房的风险:CROSS评分的制定和评估","authors":"Weiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, Florian Kurth, Tilman Lingscheid, Charlotte Thibeault, Hans-Jakob Meyer, Norbert Suttorp, Mirja Mittermaier, Melanie Stecher, Margarete Scherer, Marina Hagen, Lazar Mitrov, Ramsia Geisler, Katharina S Appel, Sina M Hopff, Carolin Koll, Susana M Nunes de Miranda, Christina Weismantel, Jens-Peter Reese, Peter Heuschmann, Olga Miljukov, Carolin Nürnberger, Leif-Erik Sander, Jörg Janne Vehreschild, Martin Witzenrath, Maarten van Smeden, Thomas Zoller","doi":"10.1093/cid/ciaf006","DOIUrl":null,"url":null,"abstract":"Background Existing risk evaluation tools underperform in predicting intensive care unit (ICU) admission for patients with the Coronavirus Disease 2019 (COVID-19). This study aimed to develop and evaluate an accurate and calculator-free clinical tool for predicting ICU admission at emergency room (ER) presentation. Methods Data from patients with COVID-19 in a nationwide German cohort (March 2020-January 2023) were analyzed. Candidate predictors were selected based on literature and clinical expertise. A risk score, predicting ICU admission within seven days of ER presentation, was developed using elastic net logistic regression on a northern German cohort (derivation cohort), evaluated on a southern German cohort (evaluation cohort) and externally validated on a Colombian cohort. Performance was evaluated through discrimination, calibration, and clinical utility against existing tools. Results ICU admission rates within seven days were 30.8% (derivation cohort, n=1295, median age 60, 38.1% female), 28.1% (evaluation cohort, n=1123, median age 58, 36.9% female), and 30.3% (Colombian cohort, n=780, median age 57, 38.8% female). The 11-point CROSS score, based on Confusion, Respiratory rate, Oxygen Saturation (with or without concurrent supplemental oxygen), and oxygen Supplementation, demonstrated good discrimination (area under the curve (AUC): 0.77 in the evaluation cohort; 0.69 in the Colombian cohort), good calibration, and superior clinical utility compared to existing tools. Mortality-predicting tools performed poorly in predicting ICU admission risk for patients with COVID-19. Conclusions The calculator-free CROSS score effectively predicts ICU admission for patients with COVID-19 in the ER. Further studies are needed to assess its generalizability in other settings. Mortality-predicting tools are not recommended for ICU admission prediction.","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":"74 1","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Predicting the risk of intensive care unit admission in patients with COVID-19 presenting in the emergency room: Development and evaluation of the CROSS score\",\"authors\":\"Weiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, Florian Kurth, Tilman Lingscheid, Charlotte Thibeault, Hans-Jakob Meyer, Norbert Suttorp, Mirja Mittermaier, Melanie Stecher, Margarete Scherer, Marina Hagen, Lazar Mitrov, Ramsia Geisler, Katharina S Appel, Sina M Hopff, Carolin Koll, Susana M Nunes de Miranda, Christina Weismantel, Jens-Peter Reese, Peter Heuschmann, Olga Miljukov, Carolin Nürnberger, Leif-Erik Sander, Jörg Janne Vehreschild, Martin Witzenrath, Maarten van Smeden, Thomas Zoller\",\"doi\":\"10.1093/cid/ciaf006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Existing risk evaluation tools underperform in predicting intensive care unit (ICU) admission for patients with the Coronavirus Disease 2019 (COVID-19). This study aimed to develop and evaluate an accurate and calculator-free clinical tool for predicting ICU admission at emergency room (ER) presentation. Methods Data from patients with COVID-19 in a nationwide German cohort (March 2020-January 2023) were analyzed. Candidate predictors were selected based on literature and clinical expertise. A risk score, predicting ICU admission within seven days of ER presentation, was developed using elastic net logistic regression on a northern German cohort (derivation cohort), evaluated on a southern German cohort (evaluation cohort) and externally validated on a Colombian cohort. Performance was evaluated through discrimination, calibration, and clinical utility against existing tools. Results ICU admission rates within seven days were 30.8% (derivation cohort, n=1295, median age 60, 38.1% female), 28.1% (evaluation cohort, n=1123, median age 58, 36.9% female), and 30.3% (Colombian cohort, n=780, median age 57, 38.8% female). The 11-point CROSS score, based on Confusion, Respiratory rate, Oxygen Saturation (with or without concurrent supplemental oxygen), and oxygen Supplementation, demonstrated good discrimination (area under the curve (AUC): 0.77 in the evaluation cohort; 0.69 in the Colombian cohort), good calibration, and superior clinical utility compared to existing tools. Mortality-predicting tools performed poorly in predicting ICU admission risk for patients with COVID-19. Conclusions The calculator-free CROSS score effectively predicts ICU admission for patients with COVID-19 in the ER. Further studies are needed to assess its generalizability in other settings. Mortality-predicting tools are not recommended for ICU admission prediction.\",\"PeriodicalId\":10463,\"journal\":{\"name\":\"Clinical Infectious Diseases\",\"volume\":\"74 1\",\"pages\":\"\"},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/cid/ciaf006\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciaf006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景现有风险评估工具在预测2019冠状病毒病(COVID-19)患者入住重症监护病房(ICU)方面表现不佳。本研究旨在开发和评估一种准确且无计算器的临床工具,用于预测急诊室(ER)的入住情况。方法分析2020年3月至2023年1月德国全国性队列中COVID-19患者的数据。候选预测因子是根据文献和临床专业知识选择的。在德国北部队列(衍生队列)中使用弹性网络逻辑回归,在德国南部队列(评估队列)中进行评估,并在哥伦比亚队列中进行外部验证,建立了预测急诊7天内入住ICU的风险评分。通过区分、校准和对现有工具的临床效用来评估性能。结果7天内ICU住院率分别为30.8%(衍生队列,n=1295,中位年龄60,女性38.1%)、28.1%(评估队列,n=1123,中位年龄58,女性36.9%)和30.3%(哥伦比亚队列,n=780,中位年龄57,女性38.8%)。基于混淆、呼吸率、血氧饱和度(是否同时补充氧气)和氧气补充的11分CROSS评分显示出良好的辨别能力(在评估队列中,曲线下面积(AUC): 0.77;0.69(哥伦比亚队列),良好的校准,与现有工具相比具有优越的临床实用性。死亡率预测工具在预测COVID-19患者ICU入院风险方面表现不佳。结论无计算器CROSS评分可有效预测急诊COVID-19患者的ICU入院情况。需要进一步的研究来评估其在其他情况下的普遍性。不建议使用死亡率预测工具来预测ICU的入院情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Predicting the risk of intensive care unit admission in patients with COVID-19 presenting in the emergency room: Development and evaluation of the CROSS score
Background Existing risk evaluation tools underperform in predicting intensive care unit (ICU) admission for patients with the Coronavirus Disease 2019 (COVID-19). This study aimed to develop and evaluate an accurate and calculator-free clinical tool for predicting ICU admission at emergency room (ER) presentation. Methods Data from patients with COVID-19 in a nationwide German cohort (March 2020-January 2023) were analyzed. Candidate predictors were selected based on literature and clinical expertise. A risk score, predicting ICU admission within seven days of ER presentation, was developed using elastic net logistic regression on a northern German cohort (derivation cohort), evaluated on a southern German cohort (evaluation cohort) and externally validated on a Colombian cohort. Performance was evaluated through discrimination, calibration, and clinical utility against existing tools. Results ICU admission rates within seven days were 30.8% (derivation cohort, n=1295, median age 60, 38.1% female), 28.1% (evaluation cohort, n=1123, median age 58, 36.9% female), and 30.3% (Colombian cohort, n=780, median age 57, 38.8% female). The 11-point CROSS score, based on Confusion, Respiratory rate, Oxygen Saturation (with or without concurrent supplemental oxygen), and oxygen Supplementation, demonstrated good discrimination (area under the curve (AUC): 0.77 in the evaluation cohort; 0.69 in the Colombian cohort), good calibration, and superior clinical utility compared to existing tools. Mortality-predicting tools performed poorly in predicting ICU admission risk for patients with COVID-19. Conclusions The calculator-free CROSS score effectively predicts ICU admission for patients with COVID-19 in the ER. Further studies are needed to assess its generalizability in other settings. Mortality-predicting tools are not recommended for ICU admission prediction.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Infectious Diseases
Clinical Infectious Diseases 医学-传染病学
CiteScore
25.00
自引率
2.50%
发文量
900
审稿时长
3 months
期刊介绍: Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.
期刊最新文献
Bridging Ophthalmology and Infectious Diseases: Insights into the Pathophysiology of Retinal Necrosis. Enhancing Influenza Vaccination for Adults Aged 50-64: Addressing Moderate Vaccine Efficacy. Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis. The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1